The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progression.
Saved in:
| Title: | The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progression. |
|---|---|
| Authors: | Lin HY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR., Mohammadhosseini M; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR., McClatchy J; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR., Villamor-Payà M; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Jeng S; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR., Bottomly D; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR., Tsai CF; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA., Posso C; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA., Jacobson J; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA., Adey A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR., Gosline S; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA.; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR., Liu T; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA., McWeeney S; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR., Stracker TH; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Agarwal A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR. |
| Source: | Blood [Blood] 2024 Jun 27; Vol. 143 (26), pp. 2749-2762. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38498025 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+HY%22">Lin HY</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Mohammadhosseini+M%22">Mohammadhosseini M</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22McClatchy+J%22">McClatchy J</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Villamor-Payà+M%22">Villamor-Payà M</searchLink>; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Jeng+S%22">Jeng S</searchLink>; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Bottomly+D%22">Bottomly D</searchLink>; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Tsai+CF%22">Tsai CF</searchLink>; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA.<br /><searchLink fieldCode="AU" term="%22Posso+C%22">Posso C</searchLink>; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA.<br /><searchLink fieldCode="AU" term="%22Jacobson+J%22">Jacobson J</searchLink>; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA.<br /><searchLink fieldCode="AU" term="%22Adey+A%22">Adey A</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Gosline+S%22">Gosline S</searchLink>; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA.; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Liu+T%22">Liu T</searchLink>; Biological Science Division, Pacific Northwest National Laboratory, Richland, WA.<br /><searchLink fieldCode="AU" term="%22McWeeney+S%22">McWeeney S</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Stracker+TH%22">Stracker TH</searchLink>; Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain.; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Agarwal+A%22">Agarwal A</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR.; Department of Oncogenic Science, Oregon Health & Science University, Portland, OR.; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR.; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2024 Jun 27; Vol. 143 (26), pp. 2749-2762. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38498025 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2023022079 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2749 Titles: – TitleFull: The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin HY – PersonEntity: Name: NameFull: Mohammadhosseini M – PersonEntity: Name: NameFull: McClatchy J – PersonEntity: Name: NameFull: Villamor-Payà M – PersonEntity: Name: NameFull: Jeng S – PersonEntity: Name: NameFull: Bottomly D – PersonEntity: Name: NameFull: Tsai CF – PersonEntity: Name: NameFull: Posso C – PersonEntity: Name: NameFull: Jacobson J – PersonEntity: Name: NameFull: Adey A – PersonEntity: Name: NameFull: Gosline S – PersonEntity: Name: NameFull: Liu T – PersonEntity: Name: NameFull: McWeeney S – PersonEntity: Name: NameFull: Stracker TH – PersonEntity: Name: NameFull: Agarwal A IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 06 Text: 2024 Jun 27 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 143 – Type: issue Value: 26 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |